Lataa...
OBESITY, New life for anti-diabetic drugs
Anti-diabetic drugs that activate the protein PPARγ had a bright start but soon lost appeal due to undesirable side effects. Subtle modifications may once again make them suitable for treating diabetes.
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3852809/ https://ncbi.nlm.nih.gov/pubmed/20651677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/466443a |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|